Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure

PURPOSE: Shensong Yangxin (SSYX) capsule is a traditional Chinese medicine that has been used widely to treat cardiac arrhythmia. This study aimed to assess whether SSYX prevents atrial fibrillation (AF) after chronic myocardial infarction (MI)-induced heart failure and to determine the underlying m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jin, Yin, Chunxia, Ma, Shiyu, Qiu, Huiliang, Zheng, Chaoyang, Chen, Qiuxiong, Ding, Chunhua, Lv, Weihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186904/
https://www.ncbi.nlm.nih.gov/pubmed/30349194
http://dx.doi.org/10.2147/DDDT.S182834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186904/
https://www.ncbi.nlm.nih.gov/pubmed/30349194
http://dx.doi.org/10.2147/DDDT.S182834

Ejemplares similares